Novyra Pharmachem Limited (BOM:519353)
10.67
0.00 (0.00%)
At close: Aug 21, 2026
Novyra Pharmachem Revenue
Novyra Pharmachem had revenue of 17.26M INR in the quarter ending June 30, 2026, with 5,653.67% growth. This brings the company's revenue in the last twelve months to 18.01M, up 2,208.33% year-over-year. In the fiscal year ending March 31, 2026, Novyra Pharmachem had annual revenue of 1.04M.
Revenue (ttm)
18.01M
Revenue Growth
+2,208.33%
P/S Ratio
3.69
Revenue / Employee
6.10M
Employees
3
Market Cap
67.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 1.50M | - | - |
| Mar 31, 2022 | 1.50M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Elegant Floriculture & Agrotech (India) | 1.48B |
| Stanbik Agro | 858.95M |
| Unisem Agritech | 810.34M |
| Omega AG Seeds Punjab | 100.78M |
| Raghuvansh Agrofarms | 76.71M |
| Shree Ganesh Bio-Tech (India) | 50.17M |
| TGIF Agribusiness | 33.18M |
| Genomic Valley Biotech | 2.16M |